KR20140051912A - Ｎ-헤테로 고리 치환 아미드 유도체 - Google Patents
Ｎ-헤테로 고리 치환 아미드 유도체 Download PDFInfo
- Publication number
- KR20140051912A KR20140051912A KR1020147001993A KR20147001993A KR20140051912A KR 20140051912 A KR20140051912 A KR 20140051912A KR 1020147001993 A KR1020147001993 A KR 1020147001993A KR 20147001993 A KR20147001993 A KR 20147001993A KR 20140051912 A KR20140051912 A KR 20140051912A
- Authority
- KR
- South Korea
- Prior art keywords
- oxadiazol
- benzamide
- mmol
- fluoro
- compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2011166248 | 2011-07-29 | ||
| JPJP-P-2011-166248 | 2011-07-29 | ||
| PCT/JP2012/069098 WO2013018675A1 (fr) | 2011-07-29 | 2012-07-27 | Dérivé d'amine substitué par un n-hétérocycle |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20140051912A true KR20140051912A (ko) | 2014-05-02 |
Family
ID=47629199
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020147001993A KR20140051912A (ko) | 2011-07-29 | 2012-07-27 | Ｎ-헤테로 고리 치환 아미드 유도체 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US9006273B2 (fr) |
| EP (1) | EP2738168B1 (fr) |
| JP (1) | JP5973440B2 (fr) |
| KR (1) | KR20140051912A (fr) |
| CN (1) | CN103827111B (fr) |
| AU (1) | AU2012291150A1 (fr) |
| BR (1) | BR112014001767A2 (fr) |
| CA (1) | CA2843238C (fr) |
| CO (1) | CO6862161A2 (fr) |
| HK (1) | HK1198033A1 (fr) |
| IL (1) | IL230655A0 (fr) |
| MX (1) | MX2014000929A (fr) |
| RU (1) | RU2014102743A (fr) |
| TW (1) | TWI529169B (fr) |
| WO (1) | WO2013018675A1 (fr) |
| ZA (1) | ZA201400407B (fr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2861847A1 (fr) * | 2012-01-18 | 2013-07-25 | Daiichi Sankyo Company, Limited | Derive de phenylazole substitue |
| JP2017119628A (ja) * | 2014-05-09 | 2017-07-06 | 日産化学工業株式会社 | 置換アゾール化合物及び糖尿病治療薬 |
| CN105181861A (zh) * | 2015-04-24 | 2015-12-23 | 上海应用技术学院 | 一种利用柱前衍生对3-氨基吡咯烷盐酸盐进行分析的方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU712057B2 (en) | 1996-06-07 | 1999-10-28 | Merck & Co., Inc. | Oxadiazole benzenesulfonamides as selective beta3 agonists for the treatment of diabetes and obesity |
| GB0029974D0 (en) * | 2000-12-08 | 2001-01-24 | Glaxo Group Ltd | Chemical compounds |
| NZ547965A (en) | 2003-12-24 | 2009-12-24 | Prosidion Ltd | 1,2,4-Oxadiazole derivatives as GPCR receptor agonists |
| JP5114395B2 (ja) | 2005-06-30 | 2013-01-09 | プロシディオン・リミテッド | Ｇｐｃｒアゴニスト |
| BRPI0613505A2 (pt) | 2005-06-30 | 2011-01-11 | Prosidion Ltd | agonistas de gpcr |
| GB0606913D0 (en) * | 2006-04-06 | 2006-05-17 | Prosidion Ltd | Compounds |
| MX2008012814A (es) | 2006-04-06 | 2008-10-17 | Prosidion Ltd | Agonistas del receptor acoplado a la proteina g heterociclicos. |
| EP2068871B1 (fr) | 2006-09-25 | 2013-12-25 | PTC Therapeutics, Inc. | Composés d'acide 1,2,4-oxadiozole benzoïque hydroxylé,leurs compositions et leur utilisation pour une suppression non-sens |
| MX2011000179A (es) | 2008-07-03 | 2011-04-05 | Astellas Pharma Inc | Derivado de triazol o su sal. |
| KR20120051670A (ko) | 2009-08-05 | 2012-05-22 | 다이이찌 산쿄 가부시키가이샤 | 아미드 유도체 |
| ES2532706T3 (es) | 2010-10-14 | 2015-03-31 | Daiichi Sankyo Company, Limited | Derivados de acilbenceno |
-
2012
- 2012-07-27 RU RU2014102743/04A patent/RU2014102743A/ru not_active Application Discontinuation
- 2012-07-27 TW TW101127098A patent/TWI529169B/zh active
- 2012-07-27 BR BR112014001767A patent/BR112014001767A2/pt not_active IP Right Cessation
- 2012-07-27 MX MX2014000929A patent/MX2014000929A/es unknown
- 2012-07-27 KR KR1020147001993A patent/KR20140051912A/ko not_active Application Discontinuation
- 2012-07-27 EP EP12820526.7A patent/EP2738168B1/fr not_active Not-in-force
- 2012-07-27 JP JP2013526870A patent/JP5973440B2/ja not_active Expired - Fee Related
- 2012-07-27 WO PCT/JP2012/069098 patent/WO2013018675A1/fr active Application Filing
- 2012-07-27 CA CA2843238A patent/CA2843238C/fr not_active Expired - Fee Related
- 2012-07-27 AU AU2012291150A patent/AU2012291150A1/en not_active Abandoned
- 2012-07-27 CN CN201280047243.XA patent/CN103827111B/zh not_active Expired - Fee Related
- 2012-07-27 US US14/235,331 patent/US9006273B2/en not_active Expired - Fee Related
-
2014
- 2014-01-17 ZA ZA2014/00407A patent/ZA201400407B/en unknown
- 2014-01-26 IL IL230655A patent/IL230655A0/en unknown
- 2014-01-28 CO CO14016982A patent/CO6862161A2/es active IP Right Grant
- 2014-11-20 HK HK14111721.7A patent/HK1198033A1/zh not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| BR112014001767A2 (pt) | 2017-02-14 |
| US20140221437A1 (en) | 2014-08-07 |
| IL230655A0 (en) | 2014-03-31 |
| EP2738168B1 (fr) | 2016-04-06 |
| AU2012291150A1 (en) | 2014-02-20 |
| EP2738168A4 (fr) | 2015-03-04 |
| NZ620339A (en) | 2016-02-26 |
| JPWO2013018675A1 (ja) | 2015-03-05 |
| RU2014102743A (ru) | 2015-09-10 |
| JP5973440B2 (ja) | 2016-08-23 |
| TWI529169B (zh) | 2016-04-11 |
| CN103827111A (zh) | 2014-05-28 |
| HK1198033A1 (zh) | 2015-03-06 |
| EP2738168A1 (fr) | 2014-06-04 |
| CA2843238A1 (fr) | 2013-02-07 |
| CN103827111B (zh) | 2016-03-23 |
| US9006273B2 (en) | 2015-04-14 |
| WO2013018675A1 (fr) | 2013-02-07 |
| CA2843238C (fr) | 2016-08-30 |
| ZA201400407B (en) | 2014-11-26 |
| CO6862161A2 (es) | 2014-02-10 |
| MX2014000929A (es) | 2014-05-12 |
| TW201309687A (zh) | 2013-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5292100B2 (ja) | Ｇｋ活性化作用を有する２−ピリジンカルボキサミド誘導体 | |
| US8394807B2 (en) | Quinazoline inhibitors of BACE 1 and methods of using | |
| US11472784B2 (en) | Griseofulvin compound | |
| US20100292259A1 (en) | Pyrimidyl indoline compound | |
| KR20100015414A (ko) | 히드록시스테로이드 탈수소효소 억제제로서 인돌- 및 벤즈이미다졸 아미드 | |
| KR20080076916A (ko) | 치환된 아미드의 약학적 사용 | |
| US20200181104A1 (en) | Ssao inhibitors and uses thereof | |
| KR101829086B1 (ko) | 아실벤젠 유도체 | |
| JPWO2010106988A1 (ja) | アミド誘導体 | |
| KR20140051912A (ko) | Ｎ-헤테로 고리 치환 아미드 유도체 | |
| KR20140113688A (ko) | 치환 페닐아졸 유도체 | |
| US8859590B2 (en) | Inhibitors of BACE1 and methods for treating Alzheimer's disease | |
| JP2007516154A (ja) | アゾリジンカーボニトリル類及びそれらのｄｐｐ−ｉｖ阻害剤としての用途 | |
| EP2940008B1 (fr) | Nouveau dérivé de benzazépine et utilisation pharmaceutique associée | |
| JP5546543B2 (ja) | スルホン誘導体 | |
| WO2016072402A1 (fr) | Dérivé d'amine cyclique | |
| US12054477B2 (en) | Prodrug of pyrrolidone derivatives as glucokinase activator | |
| NZ620339B2 (en) | N-hetero-ring-substituted amide derivative | |
| EP2411383B1 (fr) | Derives de 3-alcoxy-4,5-diarylthiophene-2-carboxamide, leur preparation et leur application en therapeutique | |
| JP2012126656A (ja) | ジヒドロインデン−１，４’−ピペリジン化合物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |